Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases

the PREVAC study team

doi:10.1038/s41467-024-51453-z

Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases

the PREVAC study team

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Abstract

In this immunological ancillary study of the PREVAC trial, the authors show that approved Ebola virus vaccines induce memory T-cell responses that persist during the five year follow-up after initial vaccination.

Original language	English (US)
Article number	7666
Journal	Nature communications
Volume	15
Issue number	1
DOIs	https://doi.org/10.1038/s41467-024-51453-z
State	Published - Dec 2024

Bibliographical note

Publisher Copyright:
© The Author(s) 2024.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Publisher link

10.1038/s41467-024-51453-z

Find It

Find It at U of M Libraries

Cite this

@article{5f41c4eaf3c04736b996c543515f603b,

title = "Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases",

abstract = "In this immunological ancillary study of the PREVAC trial, the authors show that approved Ebola virus vaccines induce memory T-cell responses that persist during the five year follow-up after initial vaccination.",

author = "\{the PREVAC study team\} and Aur{\'e}lie Wiedemann and Edouard Lhomme and M{\'e}lanie Huchon and Emile Foucat and Marion B{\'e}rerd-Camara and Lydia Guillaumat and Marcel Yaradouno and Jacqueline Tambalou and C{\'e}cile Rodrigues and Alexandre Ribeiro and B{\'e}avogui, \{Abdoul Habib\} and Christine Lacabaratz and Rodolphe Thi{\'e}baut and Laura Richert and Yves L{\'e}vy and Huanying Zhou and Zara Zeggani and Shuiqing Yu and Yazdan Yazdanpanah and Quiawiah Yarmie and Delphine Yamadjako and Alie Wurie and Jayanthi Wolf and Barthalomew Wilson and Wouter Willems and Aurelie Wiedemann and Jimmy Whitworth and Hilary Whitworth and Cecelia Wesseh and Deborah Wentworth and Wade Weaver and Deborah Watson-Jones and Travis Warren and Cedrick Wallet and Susan Vogel and Corine Vincent and Renaud Vatrinet and David Vall{\'e}e and Tijili Tyee and Awa Traore and Stacey Traina and Elvis Towalid and Abdoulaye Tour{\'e} and Daniel Tindanbil and John Tierney and Greg Thompson and Rodolphe Thiebaut and Birgit Grund and Greg Grandits and Bionca Davis",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

year = "2024",

month = dec,

doi = "10.1038/s41467-024-51453-z",

language = "English (US)",

volume = "15",

journal = "Nature communications",

issn = "2041-1723",

publisher = "Nature Research",

number = "1",

}

TY - JOUR

T1 - Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases

AU - the PREVAC study team

AU - Wiedemann, Aurélie

AU - Lhomme, Edouard

AU - Huchon, Mélanie

AU - Foucat, Emile

AU - Bérerd-Camara, Marion

AU - Guillaumat, Lydia

AU - Yaradouno, Marcel

AU - Tambalou, Jacqueline

AU - Rodrigues, Cécile

AU - Ribeiro, Alexandre

AU - Béavogui, Abdoul Habib

AU - Lacabaratz, Christine

AU - Thiébaut, Rodolphe

AU - Richert, Laura

AU - Lévy, Yves

AU - Zhou, Huanying

AU - Zeggani, Zara

AU - Yu, Shuiqing

AU - Yazdanpanah, Yazdan

AU - Yarmie, Quiawiah

AU - Yamadjako, Delphine

AU - Wurie, Alie

AU - Wolf, Jayanthi

AU - Wilson, Barthalomew

AU - Willems, Wouter

AU - Wiedemann, Aurelie

AU - Whitworth, Jimmy

AU - Whitworth, Hilary

AU - Wesseh, Cecelia

AU - Wentworth, Deborah

AU - Weaver, Wade

AU - Watson-Jones, Deborah

AU - Warren, Travis

AU - Wallet, Cedrick

AU - Vogel, Susan

AU - Vincent, Corine

AU - Vatrinet, Renaud

AU - Vallée, David

AU - Tyee, Tijili

AU - Traore, Awa

AU - Traina, Stacey

AU - Towalid, Elvis

AU - Touré, Abdoulaye

AU - Tindanbil, Daniel

AU - Tierney, John

AU - Thompson, Greg

AU - Thiebaut, Rodolphe

AU - Grund, Birgit

AU - Grandits, Greg

AU - Davis, Bionca

PY - 2024/12

Y1 - 2024/12

N2 - In this immunological ancillary study of the PREVAC trial, the authors show that approved Ebola virus vaccines induce memory T-cell responses that persist during the five year follow-up after initial vaccination.

AB - In this immunological ancillary study of the PREVAC trial, the authors show that approved Ebola virus vaccines induce memory T-cell responses that persist during the five year follow-up after initial vaccination.

UR - https://www.scopus.com/pages/publications/85203230839

UR - https://www.scopus.com/pages/publications/85203230839#tab=citedBy

U2 - 10.1038/s41467-024-51453-z

DO - 10.1038/s41467-024-51453-z

M3 - Article

C2 - 39227399

AN - SCOPUS:85203230839

SN - 2041-1723

VL - 15

JO - Nature communications

JF - Nature communications

IS - 1

M1 - 7666

ER -

Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases

Abstract

Bibliographical note

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this